Real-time enrollment status for this immune thrombocytopenia clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 4:02 AM UTC
| NCT Number | NCT06722235 |
| Recruiting Status | Recruiting |
| Condition | Immune Thrombocytopenia |
| Phase | PHASE3 |
| Target Enrollment | 171 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 19, 2026: Clinical trial NCT06722235 is currently recruiting participants. This phase3 study for immune thrombocytopenia is actively seeking new participants at 18 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06722235 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06722235 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.